SCHEMBL8103630

SCHEMBL8103630

CN(C)CCc1c[nH]c2ccc(C(N)c3nncn3C)cc12

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 14/20 0.62
HTR2C P28335 11/20 0.62
HTR1D P28221 7/20 0.60
HTR1B P28222 6/20 0.60
HTR2A P28223 4/20 0.50
MPO P05164 1/20 0.50
SLC6A4 P31645 1/20 0.50
HTR2B P41595 3/20 0.48
HTR3E A5X5Y0 2/20 0.48
HTR3B O95264 2/20 0.48
HTR1E P28566 2/20 0.48
HTR1F P30939 2/20 0.48
HTR7 P34969 2/20 0.48
HTR3A P46098 2/20 0.48
HTR5A P47898 2/20 0.48
HTR6 P50406 2/20 0.48
HTR4 Q13639 2/20 0.48
HTR3D Q70Z44 2/20 0.48
HTR3C Q8WXA8 2/20 0.48
CYP1A2 P05177 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8113709 0.84 HTR1D (0.59) HTR1AHTR2CHTR1DHTR1BHTR2A
SCHEMBL8104561 0.82 HTR1A (0.61) HTR1AHTR2CHTR1DHTR1BHTR2A
SCHEMBL8112396 0.80 HTR1D (0.60) HTR1AHTR2CHTR1DHTR1BHTR2A
SCHEMBL8113315 0.76 HTR1D (0.64) HTR1AHTR2CHTR1DHTR1BHTR2A
SCHEMBL9274413 0.76 HTR1D (0.60) HTR1AHTR2CHTR1DHTR1BHTR2A
SCHEMBL7809973 0.75 HTR1D (0.72) HTR1AHTR2CHTR1DHTR1BHTR2A
SCHEMBL8103634 0.74 HTR1A (0.69) HTR1AHTR2CHTR1DHTR1BHTR2A
SCHEMBL8783853 0.72 HTR1D (0.67) HTR1AHTR2CHTR1DHTR1BHTR2A
SCHEMBL6943364 0.72 HTR1D (1.00) HTR1AHTR2CHTR1DHTR1BHTR2A
SCHEMBL1121997 0.70 HTR1A (0.68) HTR1AHTR2CHTR1DHTR1BHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0637307-B1 IMIDAZOLE, TRIAZOLE AND TETRAZOLE DERIVATIVES MERCK SHARP & DOHME (GB) 2000-11-08 EP claimed
US-5607957-A CONTAINING ALSO INDOLE, BENZOFURAN, BENZTHIOPHENE OR INDAZOLE MOIETY; METHOD FOR TREATMENT AND/OR PREVENTION OF CLINICAL CONDITIONS FOR WHICH A SELECTIVE AGONIST OF 5-HT1-LIKE RECEPTORS IS INDICATED MERCK SHARP & DOHME LTD. (GB) 1997-03-04 US claimed
EP-0637307-A1 IMIDAZOLE, TRIAZOLE AND TETRAZOLE DERIVATIVES MERCK SHARP & DOHME LTD. (GB) 1995-02-08 EP claimed
WO-1993020066-A1 IMIDAZOLE, TRIAZOLE AND TETRAZOLE DERIVATIVES MERCK SHARP & DOHME LIMITED (GB) 1993-10-14 WO claimed
EP-0637307-B1 IMIDAZOLE, TRIAZOLE AND TETRAZOLE DERIVATIVES MERCK SHARP & DOHME (GB) 2000-11-08 EP disclosed
US-5607957-A CONTAINING ALSO INDOLE, BENZOFURAN, BENZTHIOPHENE OR INDAZOLE MOIETY; METHOD FOR TREATMENT AND/OR PREVENTION OF CLINICAL CONDITIONS FOR WHICH A SELECTIVE AGONIST OF 5-HT1-LIKE RECEPTORS IS INDICATED MERCK SHARP & DOHME LTD. (GB) 1997-03-04 US disclosed
EP-0637307-A1 IMIDAZOLE, TRIAZOLE AND TETRAZOLE DERIVATIVES MERCK SHARP & DOHME LTD. (GB) 1995-02-08 EP disclosed
WO-1993020066-A1 IMIDAZOLE, TRIAZOLE AND TETRAZOLE DERIVATIVES MERCK SHARP & DOHME LIMITED (GB) 1993-10-14 WO disclosed